Impact of adding nintedanib to neoadjuvant chemotherapy (NACT) for advanced epithelial ovarian cancer (EOC) patients: The CHIVA double-blind randomized phase II GINECO study.

Affiliation auteurs!!!! Error affiliation !!!!
TitreImpact of adding nintedanib to neoadjuvant chemotherapy (NACT) for advanced epithelial ovarian cancer (EOC) patients: The CHIVA double-blind randomized phase II GINECO study.
Type de publicationJournal Article
Year of Publication2019
AuteursFerron G, De Rauglaudre G, Chevalier A, Combe P, Joly F, Lortholary A, Raban N, Hamizi S, Malaurie E, Kaminsky M-C, Pautier P, Meunier J, Alexandre J, Berton-Rigaud D, Floquet A, Venat-Bouvet L, Favier L, Dohollou N, Dubot C, Ray-Coquard ILaure
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2019.37.15_suppl.5512